Status:
COMPLETED
Study of the Anti-Inflammatory Effects of Colgate Total® During an Experimental Gingivitis Model
Lead Sponsor:
University of Michigan
Conditions:
Gingivitis
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
This study evaluates the anti-inflammatory effects of Colgate Total® during an experimental gingivitis model developed by Löe et al. Half of the participants will use Colgate Total® (which contains tr...
Detailed Description
This will be a double-blind. Subjects will be randomly assigned to the test or control dentifrice arm. Enrolled subjects will also be randomly assigned to either right or left side mandibular stent. ...
Eligibility Criteria
Inclusion
- Race - all
- Gender - female or male
- Age - 18 to 40 years old
- Dentition - minimum of 20 permanent teeth
- Probing Pocket Depth of 1-4mm in all sites
- Mean Clinical Attachment Levels of 2mm on all teeth
- Bleeding Upon Probing of greater than 30% at Day -14 Study Visit
- Consent Form - read, understood, and signed
- Study Procedures - willing to follow all study procedures
- At Day 0 Study Visit, all subjects must have a BOP of less than 10%. Subjects not meeting the BOP study criteria will be asked to return in 2 weeks for a second assessment visit. Subjects who do not meet the inclusion criteria
- BOP less than 10% at the second assessment visit will be exited from the
- study
Exclusion
- Medical History - a history of alcoholism or drug abuse
- Diseases of the immune system
- Medical condition that may affect outcome (neurologic or psychiatric disorders, systemic infection
- Medications - chronic medications known to affect the periodontal status (calcium antagonists anticonvulsives, immunosuppressives, anti-inflammatory medications, phenytoin, Depo-Provera contraceptive injection users
- New oral contraceptives users within 3 months of baseline or are planning on starting oral contraceptives during the study
- Hypersensitivity - previous known reaction to or oral allergy to any ingredient in the study toothpaste
- Antibiotics - antibiotic therapy within 3 months of baseline visit
- antibiotic therapy needed for infective endocarditis prophylaxis or total joint replacement
- Use of antiseptics - homecare regime using products to control dental plaque formation within 30 days prior to baseline visit
- Smoking - current smokers, smokers who quit smoking less than one year ago, or a pack-year history of more than or equal to 10 (pack-years will be calculated by multiplying the number of years smoked by the average number of cigarette packs smoked per day)
- Continine - positive urine analysis results
- Current Dental Treatment - orthodontic or periodontal treatment
- Untreated Dental Treatment - untreated carious lesions
- Defective restorations which could exacerbate during a period of oral hygiene abstinence
- Pregnant or women breast-feeding
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT01799226
Start Date
March 1 2013
End Date
December 1 2013
Last Update
January 13 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Michigan Center for Oral Health Research
Ann Arbor, Michigan, United States, 48106